Skip to main content
Erschienen in: Obesity Surgery 5/2010

01.05.2010 | Clinical Research

The Relationships Between IGF-1 and CRP, NO, Leptin, and Adiponectin During Weight Loss in the Morbidly Obese

verfasst von: Eva Pardina, Roser Ferrer, Juan Antonio Baena-Fustegueras, Albert Lecube, Jose Manuel Fort, Víctor Vargas, Roberto Catalán, Julia Peinado-Onsurbe

Erschienen in: Obesity Surgery | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The relationship between C-reactive protein (CRP), nitric oxide (NO), leptin, adiponectin, and insulin growth factor 1 (IGF-1) is poorly defined in morbidly obese patients before and after gastric bypass and, in some cases, is controversial.

Methods

We examined the plasma of 34 morbidly obese patients before and 1, 6, and 12 months after Roux-en-Y gastric bypass surgery.

Results

Obese people had more CRP (21.3 ± 1.8 μg/ml) and leptin (36.9 ± 4.0 ng/ml) than those in the control group (nonobese people: CRP = 6.9 ± 0.9 μg/ml, p < 0.0001; leptin = 7.5 ± 0.4 ng/ml, p < 0.0001). However, they had less NO (30.4 ± 2.7 nmol/ml), IGF-1 (77.5 ± 6.6 ng/ml), and adiponectin (11.1 ± 1.0 μg/ml) than those in the control group (NO = 45.8 ± 3.9 nmol/ml, p = 0.0059; IGF-1 = 202.0 ± 12.0 ng/ml, p < 0.0001; adiponectin = 18.0 ± 2.0 μg/ml, p < 0.0001). During weight loss, the amount of CRP and leptin decreased until they reached the nonobese values, but the level of NO remained lower than in nonobese people, even 1 year after surgery. The linear regression slopes were negative and very significant for leptin (p = 0.0005) and CRP (p = 0.0018) but were less significant for NO (p = 0.0221). IGF-1 displayed a very good linear regression (both negative and significant) with some anthropometric parameters, including body mass index (p = 0.0025), total fat (p = 0.0177), and the percentage of fat (p < 0.0001).

Conclusion

For the first time, we report the relationship between IGF-1 and CRP, NO, leptin, and adiponectin. For all these parameters, the best and most widely demonstrated improvements in comorbidities before and during weight loss in morbid obesity were associated with CRP and leptin.
Literatur
1.
Zurück zum Zitat Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses. 2006;67:879–91.CrossRefPubMed Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses. 2006;67:879–91.CrossRefPubMed
2.
Zurück zum Zitat Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.PubMed Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.PubMed
3.
Zurück zum Zitat Engstrom G, Hedblad B, Stavenow L, et al. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003;52:2097–101.CrossRefPubMed Engstrom G, Hedblad B, Stavenow L, et al. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003;52:2097–101.CrossRefPubMed
4.
Zurück zum Zitat Morley JJ, Kushner I. Serum C-reactive protein levels. C-reactive protein and the plasma protein response to tissue injury. Annals NY Acad Sci. 1982;389:406–17.CrossRef Morley JJ, Kushner I. Serum C-reactive protein levels. C-reactive protein and the plasma protein response to tissue injury. Annals NY Acad Sci. 1982;389:406–17.CrossRef
5.
Zurück zum Zitat Davda RK, Stepniakowski KT, Lu G, et al. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995;26:764–70.PubMed Davda RK, Stepniakowski KT, Lu G, et al. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995;26:764–70.PubMed
6.
Zurück zum Zitat Vincent HK, Powers SK, Dirks AJ, et al. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord. 2001;25:378–88.CrossRefPubMed Vincent HK, Powers SK, Dirks AJ, et al. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord. 2001;25:378–88.CrossRefPubMed
7.
Zurück zum Zitat Sledzinski T, Sledzinski M, Smolenski RT, et al. Increased serum nitric oxide concentration after bariatic surgery: a potential mechanism for cardiovascular benefit. Obes Surg. 2010;20(2):204–10. Sledzinski T, Sledzinski M, Smolenski RT, et al. Increased serum nitric oxide concentration after bariatic surgery: a potential mechanism for cardiovascular benefit. Obes Surg. 2010;20(2):204–10.
8.
Zurück zum Zitat Maniscalco M, de Laurentils G, Zedda A, et al. Exhaled nitric oxide in severe obesity: effect of weight loss. Respir Physiol Neurobiol. 2007;156(3):370–3. Maniscalco M, de Laurentils G, Zedda A, et al. Exhaled nitric oxide in severe obesity: effect of weight loss. Respir Physiol Neurobiol. 2007;156(3):370–3.
9.
Zurück zum Zitat Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292–5.CrossRefPubMed Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292–5.CrossRefPubMed
10.
Zurück zum Zitat Bouloumie A, Drexler HC, Lafontan M, et al. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83:1059–66.PubMed Bouloumie A, Drexler HC, Lafontan M, et al. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83:1059–66.PubMed
11.
Zurück zum Zitat Korda M, Kubant R, Patton S, et al. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol. 2008;295:1514–21.CrossRef Korda M, Kubant R, Patton S, et al. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol. 2008;295:1514–21.CrossRef
12.
Zurück zum Zitat Vecchione C, Maffei A, Colella S, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51:168–73.CrossRefPubMed Vecchione C, Maffei A, Colella S, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51:168–73.CrossRefPubMed
13.
Zurück zum Zitat Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784–92.CrossRefPubMed Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784–92.CrossRefPubMed
14.
Zurück zum Zitat Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–7.CrossRefPubMed Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–7.CrossRefPubMed
15.
Zurück zum Zitat Nam SY, Lee EJ, Kim KR, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes. 1997;21:355–9.CrossRef Nam SY, Lee EJ, Kim KR, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes. 1997;21:355–9.CrossRef
16.
Zurück zum Zitat Rasmussen MH, Juul A, Hilsted J. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism. Obesity. 2007;15:879–86.CrossRefPubMed Rasmussen MH, Juul A, Hilsted J. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism. Obesity. 2007;15:879–86.CrossRefPubMed
17.
Zurück zum Zitat Nyomba BLG, Johnson M, Berard L, et al. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism. 1999;48:840–4.CrossRef Nyomba BLG, Johnson M, Berard L, et al. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism. 1999;48:840–4.CrossRef
18.
Zurück zum Zitat Delafontaine P, Ku L. Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells. Cardiovascular Res. 1997;33:216–22.CrossRef Delafontaine P, Ku L. Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells. Cardiovascular Res. 1997;33:216–22.CrossRef
19.
Zurück zum Zitat Schini VB, Busse R, Vanhoutte PM. Inducible nitric oxide synthase in vascular smooth muscle. Arzneimittelforschung. 1994;44:432–5.PubMed Schini VB, Busse R, Vanhoutte PM. Inducible nitric oxide synthase in vascular smooth muscle. Arzneimittelforschung. 1994;44:432–5.PubMed
20.
Zurück zum Zitat Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci U S A. 1993;90:3024–7.CrossRefPubMed Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci U S A. 1993;90:3024–7.CrossRefPubMed
21.
Zurück zum Zitat National Cholesterol Education Program (NCEP) Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel. JAMA. 2001;285:2486–97.CrossRef National Cholesterol Education Program (NCEP) Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel. JAMA. 2001;285:2486–97.CrossRef
22.
Zurück zum Zitat Lohman TG, Roche AF, Martorell R, editors. Standardization of anthropometric measurements: The Airlie (VA) Consensus Conference. Champaign: Human Kinetics; 1988. p. 20–37. Lohman TG, Roche AF, Martorell R, editors. Standardization of anthropometric measurements: The Airlie (VA) Consensus Conference. Champaign: Human Kinetics; 1988. p. 20–37.
23.
Zurück zum Zitat Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65:105–14.CrossRefPubMed Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65:105–14.CrossRefPubMed
24.
Zurück zum Zitat Bonora E, Micciolo R, Ghiatas AA. Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism. 1995;44:1617–25.CrossRefPubMed Bonora E, Micciolo R, Ghiatas AA. Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism. 1995;44:1617–25.CrossRefPubMed
25.
Zurück zum Zitat Bouza A, Bellido D, Rodríguez B, et al. Estimation of visceral and subcutaneous abdominal fat obese patients from anthropometric regression models. Rev Esp Obes. 2008;6:153–62. Bouza A, Bellido D, Rodríguez B, et al. Estimation of visceral and subcutaneous abdominal fat obese patients from anthropometric regression models. Rev Esp Obes. 2008;6:153–62.
26.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;8:412–9.CrossRef Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;8:412–9.CrossRef
27.
Zurück zum Zitat Ricart-Jané D, Llobera M, López-Tejero MD. Anticoagulants and other preanalytical factors interfere in plasma nitrate/nitrite quantification by the Griess method. Nitric Oxide. 2002;6:178–85.CrossRefPubMed Ricart-Jané D, Llobera M, López-Tejero MD. Anticoagulants and other preanalytical factors interfere in plasma nitrate/nitrite quantification by the Griess method. Nitric Oxide. 2002;6:178–85.CrossRefPubMed
28.
Zurück zum Zitat Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed
29.
Zurück zum Zitat Donohue TJ, Dworkin LD, Lango MN, et al. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation. 1994;89:799–09.PubMed Donohue TJ, Dworkin LD, Lango MN, et al. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation. 1994;89:799–09.PubMed
30.
Zurück zum Zitat Bibollet-Bahena O, Cui QL, Almazan G. The insulin-like growth factor-1 axis and its potential as a therapeutic target in central nervous system (CNS) disorders. Cent Nerv Syst Agents Med Chem. 2009;9:95–109.PubMed Bibollet-Bahena O, Cui QL, Almazan G. The insulin-like growth factor-1 axis and its potential as a therapeutic target in central nervous system (CNS) disorders. Cent Nerv Syst Agents Med Chem. 2009;9:95–109.PubMed
31.
Zurück zum Zitat Sukhanov S, Higashi Y, Shai SY, et al. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:2684–90.CrossRefPubMed Sukhanov S, Higashi Y, Shai SY, et al. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:2684–90.CrossRefPubMed
32.
Zurück zum Zitat Muniyappa R, Walsh MF, Rangi JS, et al. Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci. 1997;61:925–31.CrossRefPubMed Muniyappa R, Walsh MF, Rangi JS, et al. Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci. 1997;61:925–31.CrossRefPubMed
33.
Zurück zum Zitat Evans JI, Maddux BA, Goldfine ID. The molecular basis for oxidative stress induced insulin resistance. Antioxid Redox Signal. 2005;7:1040–52.CrossRefPubMed Evans JI, Maddux BA, Goldfine ID. The molecular basis for oxidative stress induced insulin resistance. Antioxid Redox Signal. 2005;7:1040–52.CrossRefPubMed
34.
Zurück zum Zitat Matsuzawa-Nagata N, Takamura T, Ando H, et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism. 2008;57:1071–7.CrossRefPubMed Matsuzawa-Nagata N, Takamura T, Ando H, et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism. 2008;57:1071–7.CrossRefPubMed
35.
Zurück zum Zitat Gomez JM, Maravall FJ, Gomez N, et al. The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res. 2004;14:91–6.CrossRefPubMed Gomez JM, Maravall FJ, Gomez N, et al. The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res. 2004;14:91–6.CrossRefPubMed
36.
Zurück zum Zitat Poulos JE, Leggett-Frazier N, Khazanie P, et al. Circulating insulin-like growth factor I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss. Horm Metab Res. 1994;26:478–80.CrossRefPubMed Poulos JE, Leggett-Frazier N, Khazanie P, et al. Circulating insulin-like growth factor I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss. Horm Metab Res. 1994;26:478–80.CrossRefPubMed
37.
Zurück zum Zitat Efstratiadis G, Tsiaousis G, Athyros VG, et al. Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes. Angiology. 2006;57(3):303–11.CrossRefPubMed Efstratiadis G, Tsiaousis G, Athyros VG, et al. Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes. Angiology. 2006;57(3):303–11.CrossRefPubMed
38.
Zurück zum Zitat Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–2.CrossRefPubMed Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–2.CrossRefPubMed
39.
Zurück zum Zitat Andersson K, Gaudiot N, Ribiere C, et al. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol. 1999;126:1639–45.CrossRefPubMed Andersson K, Gaudiot N, Ribiere C, et al. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol. 1999;126:1639–45.CrossRefPubMed
40.
Zurück zum Zitat Pardina E, Lecube A, Llamas R, et al. Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients. Obes Surg. 2009;19:1150–8.CrossRefPubMed Pardina E, Lecube A, Llamas R, et al. Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients. Obes Surg. 2009;19:1150–8.CrossRefPubMed
41.
Zurück zum Zitat Cleland SJ, Sattar N, Petrie JR, et al. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci. 2000;98:531–5.CrossRefPubMed Cleland SJ, Sattar N, Petrie JR, et al. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci. 2000;98:531–5.CrossRefPubMed
42.
Zurück zum Zitat Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRefPubMed Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRefPubMed
43.
Zurück zum Zitat Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1–7.CrossRefPubMed Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1–7.CrossRefPubMed
44.
Zurück zum Zitat Brennan AM, Li TY, Kelesidis I, et al. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia. 2007;50:1178–85.CrossRefPubMed Brennan AM, Li TY, Kelesidis I, et al. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia. 2007;50:1178–85.CrossRefPubMed
45.
Zurück zum Zitat Chan DC, Watts GF, Ng TW, et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin Chem. 2005;51:578–5.CrossRefPubMed Chan DC, Watts GF, Ng TW, et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin Chem. 2005;51:578–5.CrossRefPubMed
46.
Zurück zum Zitat Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17:4–12.PubMed Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17:4–12.PubMed
47.
Zurück zum Zitat Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68:975–81.CrossRefPubMed Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68:975–81.CrossRefPubMed
48.
Zurück zum Zitat Abbasi F, Chang SA, Chu JW, et al. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol. 2006;290:139–44. Abbasi F, Chang SA, Chu JW, et al. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol. 2006;290:139–44.
49.
Zurück zum Zitat Mantzoros CS, Li T, Manson JE, et al. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005;90:4542–8.CrossRefPubMed Mantzoros CS, Li T, Manson JE, et al. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005;90:4542–8.CrossRefPubMed
50.
Zurück zum Zitat Coughlin CC, Finck BN, Eagon JC, et al. Effect of marked weight loss on adiponectin gene expression and plasma concentrations. Obesity. 2007;15:640–5.CrossRefPubMed Coughlin CC, Finck BN, Eagon JC, et al. Effect of marked weight loss on adiponectin gene expression and plasma concentrations. Obesity. 2007;15:640–5.CrossRefPubMed
Metadaten
Titel
The Relationships Between IGF-1 and CRP, NO, Leptin, and Adiponectin During Weight Loss in the Morbidly Obese
verfasst von
Eva Pardina
Roser Ferrer
Juan Antonio Baena-Fustegueras
Albert Lecube
Jose Manuel Fort
Víctor Vargas
Roberto Catalán
Julia Peinado-Onsurbe
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 5/2010
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0103-5

Weitere Artikel der Ausgabe 5/2010

Obesity Surgery 5/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.